Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$9.27
-6.39-40.80%
At close: -
$9.12
-0.15-1.62%
After Hours: 6:55 PM EDT
Comments
Loading...
Bicara Therapeutics (BCAX) Forecast
NewsEarningsBicara Therapeutics (BCAX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Bicara Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:BCAX | Benzinga
Explore Bicara Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BCAX.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Bicara Therapeutics (BCAX) stock?
You can purchase shares of Bicara Therapeutics (NASDAQ:BCAX) through any online brokerage.
Who are Bicara Therapeutics (BCAX) competitors?
Other companies in Bicara Therapeutics’s space includes: Immunome (NASDAQ:IMNM), Gyre Therapeutics (NASDAQ:GYRE), Syndax Pharmaceuticals (NASDAQ:SNDX), Replimune Group (NASDAQ:REPL) and Immatics (NASDAQ:IMTX).
What is the forecast, or price target, for Bicara Therapeutics (BCAX) stock?
Bicara Therapeutics has a consensus price target of $29.17.
What is the current price for Bicara Therapeutics (BCAX)?
The stock price for Bicara Therapeutics (NASDAQ: BCAX) is $9.12 last updated May 23, 2025 at 6:55 PM EDT.
Does Bicara Therapeutics (BCAX) pay a dividend?
There are no upcoming dividends for Bicara Therapeutics.
When is Bicara Therapeutics (NASDAQ:BCAX) reporting earnings?
Bicara Therapeutics’s Q2 earnings are confirmed for Saturday, August 16, 2025.
Is Bicara Therapeutics (BCAX) going to split?
There is no upcoming split for Bicara Therapeutics.
What sector and industry does Bicara Therapeutics (BCAX) operate in?
Bicara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
